MAP1S Controls Breast Cancer Cell TLR5 Signaling Pathway and Promotes TLR5 Signaling-based Tumor Suppression

Targeting TLR5 signaling in breast cancer represents a novel strategy in cancer immunotherapy. However, the underlying mechanism by which TLR5 signaling inhibits cancer cell proliferation and tumor growth has not been elucidated. In this study, we found TLR5 agonist flagellin inhibited the cell stat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ming, Yao, Yuanfei, Han, Fang, Li, Yiqun, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900661/
https://www.ncbi.nlm.nih.gov/pubmed/24466264
http://dx.doi.org/10.1371/journal.pone.0086839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900661/
https://www.ncbi.nlm.nih.gov/pubmed/24466264
http://dx.doi.org/10.1371/journal.pone.0086839

Ejemplares similares